Management of Neonatal Opiod Withdrawal 2 NBCC Hours
ACEonline, LLC has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6994.
Programs that do not qualify for NBCC credit are clearly identified. ACEonline, LLC is solely responsible for all aspects of programs.
To register for this course, you will be asked to create an account on our website using your name and email address. Once you have created an account, you will be asked to review and agree to terms and conditions, and then be prompted to make a payment through PayPal.
After your payment has processed, you will receive an email with login instructions. Once you login, you will be asked to create a profile with your name, address, email, phone number, and professional license number. If you do not have a professional license number, you may enter your driver's license or state identification number.
Division of Alcohol and Drug Abuse Programming at the Vermont Department of Health, the Maternal Fetal Medicine Department at Fletcher Allen Health Care and the Neomedicar Follow-Up Department at Fletcher Allen Health Care. (2010). Treatment of Opioid Dependence in Pregnancy, Vermont Guidelines, Section 4.
The subject matter in this course is "directly and primarily related to" the NBCC Content Areas, Wellness and Prevention and Counselor Professional Identity and Practice Issues, which have been specified by the NBCC Continuing Education Provider Policy as acceptable content to qualify for NBCC continuing education credit. This course is available for ACEP home study and offers 2 NBCC Hours.
This course requires the Participant to read and understand the attached article pertaining to neonatal abstinence syndrome (NAS). Neonatal abstinence syndrome (NAS) refers to a constellation of signs in the newborn due to substance or medication withdrawal. The Participant will understand how and why opioid use and dependence during pregnancy continues to be a significant health problem. Additionally, Participants will consider the guidelines for management of opioid-exposed newborns at Vermont Children’s Hospital at Fletcher Allen Health Care.
In Management of Neonatal Opioid Withdrawal, Participants will gain general knowledge about how opioid use and dependence during pregnancy gravely affects the developing fetus. Participants will also explore the guidelines for management of opioid-exposed newborns at Vermont Children’s Hospital at Fletcher Allen Health Care.
This course is designed to provide comprehensive information for the management of the opioid exposed newborn to mental health professionals, social workers, substance abuse professionals, child welfare workers, healthcare professionals, psychologists, or certified addiction specialists
To be aware of the significant public health problem that opioid use and dependence during pregnancy poses.
To comprehend the effects of opioid use and withdrawal on the developing fetus.
To identify the appropriate site of care for opioid-exposed newborns
To understand neonatal abstinence syndrome (NAS) scoring
To be familiar with the treatment techniques and how they are effective
To identify when different types of newborn drug screening should be considered
To recognize when breastfeeding is recommended for all infants
To be aware of the guidelines for the management of infants born to hepatitis C antibody positive women
To recognize the importance of discharge considerations for infants on oral methadone
To be familiar with outpatient management of neonatal opioid withdrawal and monthly multidisciplinary meetings